| S | M | T | W | T | F | S |
|---|---|---|---|---|---|---|
| 29 | 30 | 31 | 1 | 2 February 2, 2012x | 3 | 4 |
| 5 | 6 | 7 | 8 | 9 February 9, 2012x | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 February 16, 2012x | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 1 | 2 | 3 |
EVENT DATE: Thursday, October 22, 2009.
Green shoots or Brown weeds? Is the economy going to be shaped as V, W, L, or neither? Learn how understanding the economy and chemical industry trends can help you identify hidden business/job opportunities and get ahead of others; do not miss out on the chance to learn “The New Reality”.
EVENT DATE: Thursday, September 24, 2009.
Looking for hot growth areas? Want to be part of the Green Chemistry movement? Learn how the Government’s Small Business Innovation Research (SBIR) Program at the Environmental Protection Agency (EPA) may be your ticket to helping bring your idea into reality. You will also learn tips and tricks on how to find and apply for SBIR grants at other government agencies.
EVENT DATE: Thursday, August 27, 2009.
Tired of waiting for investors? Want to start building your company? Raising capital is by far the most unpleasant task entrepreneurs and small businesses will ever have to perform. The landscape for venture capital funding has also shifted in the last year. Join us to learn first hand on how to find the right funding sources and the venture capitals that can be your partners to success.
EVENT DATE: Thursday, June 25, 2009.
Learn about how to get your company off the ground and understand the pros/cons of the “spin out model.” If you want to uncover, join, or learn about the growing opportunities in spin out companies, you can’t afford to miss this event! ACS Small & Medium Business Webinar Series, June 25, 2009, 2:00-3:00pm ET.
Meet David Porter, Managing Partner of Apposite Capital and a chemist by training. He’s a driving force in finding “the next big discovery” and turning scientists into successful entrepreneurs.
Read More...Meet Mr. Al Altomari who helped launched Barrier Therapeutics spin out from Johnson & Johnson in 2002. At Barrier, Al successfully led the company from inception to Initial Public Offering, and finally sale of the company at a premium to Steifel Laboratories in 2008.
Read More...
